o-desmethylindomethacin has been researched along with rosiglitazone in 2 studies
| Studies (o-desmethylindomethacin) | Trials (o-desmethylindomethacin) | Recent Studies (post-2010) (o-desmethylindomethacin) | Studies (rosiglitazone) | Trials (rosiglitazone) | Recent Studies (post-2010) (rosiglitazone) |
|---|---|---|---|---|---|
| 27 | 0 | 4 | 4,749 | 556 | 1,818 |
| Protein | Taxonomy | o-desmethylindomethacin (IC50) | rosiglitazone (IC50) |
|---|---|---|---|
| CDGSH iron-sulfur domain-containing protein 1 | Rattus norvegicus (Norway rat) | 1.1 | |
| Bile salt export pump | Homo sapiens (human) | 4.5853 | |
| Carbonic anhydrase 2 | Homo sapiens (human) | 4.069 | |
| Peroxisome proliferator-activated receptor alpha | Mus musculus (house mouse) | 0.08 | |
| Thromboxane-A synthase | Homo sapiens (human) | 3.56 | |
| Amine oxidase [flavin-containing] B | Homo sapiens (human) | 0.832 | |
| Peroxisome proliferator-activated receptor gamma | Homo sapiens (human) | 0.2481 | |
| Mu-type opioid receptor | Cavia porcellus (domestic guinea pig) | 0.038 | |
| ATP-binding cassette sub-family C member 8 | Homo sapiens (human) | 0.048 | |
| ATP-sensitive inward rectifier potassium channel 11 | Homo sapiens (human) | 0.048 | |
| Sodium/bile acid cotransporter | Homo sapiens (human) | 5.1 | |
| CDGSH iron-sulfur domain-containing protein 2 | Homo sapiens (human) | 2.29 | |
| CDGSH iron-sulfur domain-containing protein 1 | Homo sapiens (human) | 0.731 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bansal, G; Garg, V; Maurya, RK; Monga, V; Thanikachalam, PV | 1 |
| Feng, CR; He, QJ; Li, Y; Li, YY; Tang, L; Wu, HS; Yang, B; Yang, YS; Yu, JH | 1 |
1 review(s) available for o-desmethylindomethacin and rosiglitazone
| Article | Year |
|---|---|
An insight into the medicinal perspective of synthetic analogs of indole: A review.
Topics: Animals; Anti-HIV Agents; Anti-Infective Agents; Antihypertensive Agents; Antimalarials; Antitubercular Agents; Humans; Hypoglycemic Agents; Indoles; Molecular Structure; Structure-Activity Relationship | 2019 |
1 other study(ies) available for o-desmethylindomethacin and rosiglitazone
| Article | Year |
|---|---|
The potential insulin sensitizing and glucose lowering effects of a novel indole derivative in vitro and in vivo.
Topics: 3T3-L1 Cells; Adipocytes; Adiponectin; Animals; Blood Glucose; Cell Differentiation; Cell Line, Tumor; Glucose; Glucose Transporter Type 4; Humans; Hypoglycemic Agents; In Vitro Techniques; Indoleacetic Acids; Indoles; Insulin; Insulin Resistance; Leptin; Male; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; PPAR alpha; PPAR gamma; Resistin; RNA, Messenger; Rosiglitazone; Signal Transduction; Thiazolidinediones | 2007 |